Arginine vasopressin deficiency (central diabetes insipidus)
Also known as: AVP deficiency, AVP-D, Central diabetes insipidus, Cranial diabetes insipidus, Neurohypophyseal diabetes insipidus
Arginine vasopressin deficiency (AVP-D) is characterised by insufficient vasopressin release, impairing renal urine concentration and causing polyuria, thirst, and potentially dangerous dehydration or hypernatraemia. Diagnosis and ongoing management require specialist endocrine assessment, individualised fluid planning, and usually desmopressin; associated pituitary dysfunction may require investigation. Infants necessitate particularly specialised management because nutrition, fluid requirements, and antidiuretic treatment interact. In clinically stable patients, Chinese medicine may be considered only as adjunctive support for associated discomfort, fatigue, or sleep disturbance. the cited literature contains no clinical evidence establishing acupuncture or herbal efficacy for this condition. Traditional patterns are descriptive frameworks, not measures of vasopressin function, sodium balance, or treatment adequacy.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Ensure constant access to potable water and adhere strictly to the prescribed endocrine fluid protocol; avoid both intentional fluid restriction and hyperhydration.
- •Maintain an objective record of polydipsia, nocturia, and clinical metrics requested by the physician, such as fluid intake, output volume, or body weight.
- •Possess a current pharmacological list and an AVP-D care plan at all times, including specific protocols for acute illness, travel, or hospitalisation.
- •Maintain consistent diurnal rhythms for nutrition and sleep; ensure pre-planned access to sanitation facilities and prescribed medications during occupational or travel activities.
Cautions & Contraindications
- •Defer elective acupuncture and new herbal treatment during suspected dehydration, sodium disturbance or inability to maintain prescribed fluids; medical stabilisation takes priority.[]
- •Do not replace, withhold or alter desmopressin, prescribed fluids or specialist monitoring on the basis of a TCM assessment; antidiuretic treatment and fluid intake must be coordinated to avoid sodium complications.[]
- •Do not extrapolate these adult traditional pattern options to neonates or infants. Their nutrition, fluids and pharmacological management require specialist paediatric oversight.[]
When to reassess or seek care again
For medically stable adults choosing adjunctive care, review after 2–4 weeks using a symptom-specific baseline such as nights of disrupted sleep, dry-mouth severity on a 0–10 scale, appetite and functional fatigue. Track nocturia as a medical-control signal, not proof of acupuncture efficacy. Sodium and osmolality monitoring remain directed by the endocrine team. Refer promptly for worsening thirst, urine output, weight change or pituitary symptoms; escalate immediately for red flags. Stop adjunctive treatment if adverse effects occur or there is no meaningful benefit after the agreed trial.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Hormone research in paediatrics · 2026
- BMC endocrine disorders · 2024
- Neuroscience · 2025
- BMC endocrine disorders · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
